Collectively, our data suggest that MKP-2 promotes IGF-1, SDF-1, FKN, and IL-10 signaling to contribute to development of insulin resistance, NAFLD, fibrosis, and inflammation. Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.